Pharos iBio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	118,714	121,562	98,001	191,588	-	-
Market Cap Growth	37.07%	24.04%	-48.85%	-	-	-
Enterprise Value	100,645	112,925	80,945	164,210	-	-
Last Close Price	9170.00	9390.00	7570.00	14830.00	-	-
PB Ratio	8.52	8.73	5.27	6.76	-	-
P/TBV Ratio	8.76	8.97	5.39	6.79	-	-
Debt / Equity Ratio	0.57	0.57	0.01	0.01	0.02	-0.04
Net Debt / Equity Ratio	-1.30	-1.30	-0.83	-0.89	-0.83	1.47
Net Debt / EBITDA Ratio	1.69	1.69	1.32	2.67	1.47	2.88
Net Debt / FCF Ratio	2.16	2.16	1.55	3.05	1.73	2.74
Asset Turnover	-	-	-	-	0.01	0.00
Quick Ratio	18.71	18.71	16.25	21.15	16.06	0.56
Current Ratio	18.96	18.96	16.70	21.57	16.53	0.57
Return on Equity (ROE)	-66.11%	-66.11%	-44.97%	-38.50%	-1825.61%	-
Return on Assets (ROA)	-29.06%	-29.06%	-31.94%	-26.12%	-28.73%	-23.78%
Return on Capital Employed (ROCE)	-40.40%	-40.40%	-67.50%	-35.50%	-59.80%	55.20%
Earnings Yield	-9.06%	-8.85%	-10.78%	-4.62%	-	-
FCF Yield	-7.04%	-6.88%	-10.21%	-4.31%	-	-
Buyback Yield / Dilution	-0.14%	-0.14%	-6.81%	-36.26%	-53.03%	-2.65%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.